Research map: Programmable CAR and antigen pairing for solid tumor immunotherapy

Back to the article

Papers in this map

  1. CAR-T cell therapy: current limitations and potential strategies · Robert C. Sterner · 2021 · 2926 citations · Cited by this paper
  2. CAR design equips diverse immune cells with unique antigen-specific activation identities · Ayano Sugiyama-Finnis · 2026 · Related
  3. Systematically optimized BCMA/CS1 bispecific CAR-T cells robustly control heterogeneous multiple myeloma · Eugenia Zah · 2020 · 233 citations · Cited by this paper
  4. Rethinking lymphodepleting preconditioning in adoptive T cell therapy for durable tumor control · 2026 · Related
  5. Enhancing the safety of CAR-T cell therapy: Synthetic genetic switch for spatiotemporal control · Li Lu · 2024 · 108 citations · Cited by this paper
  6. Depletion of IL-10 in CAR-NK cells augments reprogramming of the tumor microenvironment and ameliorates therapeutic efficacy · 2026 · Related
  7. A rational mouse model to detect on-target, off-tumor CAR T cell toxicity · Mauro L. Castellarin · 2020 · 105 citations · Cited by this paper
  8. AGTR1 signaling contributes to tumor immunity and therapy response in non-small cell lung cancer · 2026 · Related
  9. An AND-Gated Drug and Photoactivatable Cre-loxP System for Spatiotemporal Control in Cell-Based Therapeutics · Molly E. Allen · 2019 · 46 citations · Cited by this paper
  10. CART-immune-related adverse events after BCMA CAR-T therapy · 2026 · Related
  11. Directed Evolution to Engineer Monobody for FRET Biosensor Assembly and Imaging at Live-Cell Surface · Praopim Limsakul · 2018 · 30 citations · Cited by this paper
  12. Unmasking Wnt-driven HCC: Inhibiting SMYD2 to overcome immune resistance · 2026 · Related
  13. Optogenetic Control for Investigating Subcellular Localization of Fyn Kinase Activity in Single Live Cells · Ziliang Huang · 2020 · 7 citations · Cited by this paper
  14. Intraperitoneal delivery of the oncolytic virus CF17 improves tumor immunogenicity and survival in gastric cancer peritoneal metastasis · 2026 · Related
  15. AI-driven cellular immunotherapy: transforming CAR-T engineering and translation · Ziliang Huang · 2026 · 2 citations · Cited by this paper
  16. Synergistic Cell-Cycle Repression by HDAC/EZH2 Co-Targeting in H3K27-Altered Diffuse Midline Glioma · 2026 · Related
  17. CD19 antigen: From tumor target to safety switch able to improve the safety profile of CAR T cell therapy · Simona Manni · 2025 · 1 citation · Cited by this paper
  18. Natural killer cell-derived extracellular vesicles reprogram cellular human immunity to enhance tumor cytotoxicity · 2026 · Related
  19. Optimizing CAR T cell therapy in pancreatic cancer through clinically actionable combinations · 2026 · Related

Source: OpenAlex (CC0)